BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 11723077)

  • 1. Plasma glucose levels throughout the day and HbA(1c) interrelationships in type 2 diabetes: implications for treatment and monitoring of metabolic control.
    Bonora E; Calcaterra F; Lombardi S; Bonfante N; Formentini G; Bonadonna RC; Muggeo M
    Diabetes Care; 2001 Dec; 24(12):2023-9. PubMed ID: 11723077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATE study.
    Blonde L; Merilainen M; Karwe V; Raskin P;
    Diabetes Obes Metab; 2009 Jun; 11(6):623-31. PubMed ID: 19515182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strongest correlation of HbA(1c) with 1-month-earlier glucose levels in type 2 diabetes.
    Nakazaki M; Fukushige E; Koriyama N; Fukudome M; Hashiguchi H; Aso K; Yano J; Ikeda Y; Kato K; Tei C
    Diabetes Res Clin Pract; 2004 Mar; 63(3):171-7. PubMed ID: 14757288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of fasting and postprandial hyperglycemia to hemoglobin A1c in insulin-treated Japanese diabetic patients.
    Shimizu H; Uehara Y; Okada S; Mori M
    Endocr J; 2008 Aug; 55(4):753-6. PubMed ID: 18497454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of postprandial and fasting glucose concentrations on HbA1c in patients with type 2 diabetes.
    Schernthaner G; Guerci B; Gallwitz B; Rose L; Nicolay C; Kraus P; Kazda C
    Diabetes Metab; 2010 Nov; 36(5):389-94. PubMed ID: 20598608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attainment of glycaemic goals in type 2 diabetes with once-, twice-, or thrice-daily dosing with biphasic insulin aspart 70/30 (The 1-2-3 study).
    Garber AJ; Wahlen J; Wahl T; Bressler P; Braceras R; Allen E; Jain R
    Diabetes Obes Metab; 2006 Jan; 8(1):58-66. PubMed ID: 16367883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fasting plasma glucose 6-12 weeks after starting insulin glargine predicts likelihood of treatment success: a pooled analysis.
    Karl D; Zhou R; Vlajnic A; Riddle M
    Diabet Med; 2012 Jul; 29(7):933-6. PubMed ID: 22413808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative and absolute contributions of postprandial and fasting plasma glucose to daytime hyperglycaemia and HbA(1c) in subjects with Type 2 diabetes.
    Peter R; Dunseath G; Luzio SD; Chudleigh R; Choudhury SR; Owens DR
    Diabet Med; 2009 Oct; 26(10):974-80. PubMed ID: 19900228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of casual postprandial glucose levels in type 2 diabetes management.
    El-Kebbi IM; Ziemer DC; Cook CB; Gallina DL; Barnes CS; Phillips LS
    Diabetes Care; 2004 Feb; 27(2):335-9. PubMed ID: 14747210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of hemoglobin A1c and fasting glucose criteria to diagnose diabetes among people with metabolic syndrome and fasting glucose above 100 mg/dL (5.5 mmol/L).
    Liberopoulos EN; Florentin M; Kei A; Mountzouri E; Agouridis A; Elisaf MS
    J Clin Hypertens (Greenwich); 2010 Jul; 12(7):543-8. PubMed ID: 20629819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrovascular risk and diagnostic criteria for type 2 diabetes: implications for the use of FPG and HbA(1c) for cost-effective screening.
    Jesudason DR; Dunstan K; Leong D; Wittert GA
    Diabetes Care; 2003 Feb; 26(2):485-90. PubMed ID: 12547886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
    Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
    Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma.
    Paroni R; Ceriotti F; Galanello R; Battista Leoni G; Panico A; Scurati E; Paleari R; Chemello L; Quaino V; Scaldaferri L; Lapolla A; Mosca A
    Clin Biochem; 2007 Dec; 40(18):1398-405. PubMed ID: 17919531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensified blood glucose monitoring improves glycemic control in stable, insulin-treated veterans with type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES).
    Murata GH; Shah JH; Hoffman RM; Wendel CS; Adam KD; Solvas PA; Bokhari SU; Duckworth WC;
    Diabetes Care; 2003 Jun; 26(6):1759-63. PubMed ID: 12766106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simple way to estimate mean plasma glucose and to identify Type 2 diabetic subjects with poor glycaemic control when a standardized HbA1c assay is not available.
    Ozmen S; Cil T; Atay AE; Tuzcu AK; Bahceci M
    Diabet Med; 2006 Oct; 23(10):1151-4. PubMed ID: 16978383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of postprandial glucose to excess hyperglycaemia in Asian type 2 diabetic patients using continuous glucose monitoring.
    Wang JS; Tu ST; Lee IT; Lin SD; Lin SY; Su SL; Lee WJ; Sheu WH
    Diabetes Metab Res Rev; 2011 Jan; 27(1):79-84. PubMed ID: 21218511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.
    Rossetti P; Pampanelli S; Fanelli C; Porcellati F; Costa E; Torlone E; Scionti L; Bolli GB
    Diabetes Care; 2003 May; 26(5):1490-6. PubMed ID: 12716810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of haemoglobin A1c and fasting plasma glucose for incident diabetes and implications for screening.
    Schöttker B; Raum E; Rothenbacher D; Müller H; Brenner H
    Eur J Epidemiol; 2011 Oct; 26(10):779-87. PubMed ID: 21947790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is the relative contribution of blood glucose levels at different time points of the day to HbA1c in Type 1 diabetes?
    Hillman N; Herranz L; Grande C; Vaquero PM; Pallardo LF
    Diabet Med; 2004 May; 21(5):468-70. PubMed ID: 15089792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The glucose area under the profiles obtained with continuous glucose monitoring system relationships with HbA(lc) in pediatric type 1 diabetic patients.
    Salardi S; Zucchini S; Santoni R; Ragni L; Gualandi S; Cicognani A; Cacciari E
    Diabetes Care; 2002 Oct; 25(10):1840-4. PubMed ID: 12351488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.